At the end of the Phase 1a stage. Really we could have called it a Phase 1/2a trial. The Phase 1a is to workout the best dose, and the Phase 1b (or 2a) is where we collect efficacy data on cardioprotection and anticancer activity. I should add we collect m6A data right from the first patient in the Phase 1a.
The planning, site selection, trial structure, etc for the Phase 2 trial will start as soon as we complete the Phase 1a (ie. as soon as we know the best dose). There will be a lot of overlap between the Phase 1b and Phase 2 trials in timing.
At the end of the Phase 1a stage. Really we could have called it...
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.84 |
Change
-0.025(1.34%) |
Mkt cap ! $313.3M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.91 | $1.81 | $257.6K | 138.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26825 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.90 | 759 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |